Company Filing History:
Years Active: 2020
Title: Florian Settele: Innovator in EGFR Binding Proteins
Introduction
Florian Settele is a notable inventor based in Halle/Saale, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of innovative binding proteins.
Latest Patents
Settele holds a patent for EGFR binding proteins. This invention relates to new EGFR binding molecules based on ubiquitin muteins, specifically Affilin molecules that possess a characteristic three amino acid residue motif. The patent also covers EGFR binding molecules that target different or non-overlapping epitopes compared to the anti-EGFR monoclonal antibody Cetuximab. Furthermore, the invention highlights the application of these EGFR binding proteins in medicine, particularly for the diagnosis or treatment of cancer.
Career Highlights
Florian Settele is associated with Navigo Proteins GmbH, where he continues to advance research in protein engineering and therapeutic applications. His work has positioned him as a key figure in the biotechnology sector.
Collaborations
Settele collaborates with esteemed colleagues, including Eva Bosse-Doenecke and Erik Fiedler, contributing to a dynamic research environment that fosters innovation.
Conclusion
Florian Settele's work in developing EGFR binding proteins represents a significant advancement in cancer treatment and diagnosis. His contributions to biotechnology continue to impact the field positively.